Now that the Moderna Spikevax vaccine has been approved for children 6-11 years, PDL has offered members some advice The ATAGI approval of Moderna Spikevax for the primary vaccination of children 6-11 years provides more options for families and pharmacists. Read the ATAGI statement. Key points include: There is NO paediatric formulation. It is the
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.